The U.S. cannabis industry continues to expand rapidly, creating strong momentum for related investments. In 2025, the market is expected to surpass $44 billion in value. Over the next five years, projections suggest it could reach more than $76 billion. This steady growth is driven by rising consumer demand and ongoing legalization across many states. Currently, nearly half of U.S. adults have tried cannabis at least once. Meanwhile, almost 80% of Americans live near a licensed dispensary. The industry also supports hundreds of thousands of jobs and contributes billions to the economy each year. Because of this, investors are watching cannabis real estate investment trusts (REITs) for potential gains.

At the same time, recent news around federal rescheduling of cannabis has added to investor optimism. If the government moves cannabis to a lower schedule, many operators could see reduced tax burdens. This change would likely attract new capital and improve profitability. States like Pennsylvania are also pushing forward with new legalization bills. These efforts could bring new business to cannabis REITs and boost long-term revenue. However, smart investors must still approach this sector carefully. Using technical analysis helps identify strong price trends and good entry points. Proper risk management, such as stop losses and position sizing, also protects capital. Altogether, staying informed and disciplined is key when trading cannabis REITs in today’s evolving market.

Cannabis REITs to Watch for Long-Term Gains in 2025

As the U.S. cannabis industry expands, real estate investment trusts (REITs) are becoming a critical financing source. These REITs provide essential capital to cannabis companies through sale-leaseback agreements and direct lending. In return, they generate consistent income and strong dividends for shareholders. Moreover, they offer exposure to the cannabis sector without the risks of direct plant-touching operations. In May 2025, three cannabis REITs stand out due to their growing portfolios and resilient financials. These include Innovative Industrial Properties (IIPR), NewLake Capital Partners (NLCP), and Chicago Atlantic Real Estate Finance (REFI).

[Read More] Top Marijuana Stocks In A Volatile Market

Top Cannabis REITs to Watch in May 2025

1. Innovative Industrial Properties, Inc. (NYSE: IIPR)
2. NewLake Capital Partners, Inc. (OTC: NLCP)
3. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI)

Innovative Industrial Properties, Inc. (IIPR)

Innovative Industrial Properties is the first publicly traded cannabis REIT in the U.S. It focuses entirely on acquiring and leasing facilities to licensed cannabis operators. Founded in 2016, the company has grown steadily across the country. It operates in 19 states, with major footprints in California, Pennsylvania, and Illinois. These regions host large-scale cultivation and processing centers.

The company currently holds over 100 properties. These properties are mostly leased to single tenants under long-term triple-net leases. The tenants include some of the largest U.S. cannabis producers. As a result, IIPR maintains steady rental income even during market downturns. Its focus on real estate allows investors to gain indirect cannabis exposure with reduced volatility.

In Q1 2025, IIPR reported revenue of $71.7 million. This marked a slight increase from the previous quarter. Net income came in at $30.3 million, or $1.03 per share. The company declared a dividend of $1.90 per share. This represents a yield attractive to income-seeking investors. IIPR continues to maintain over $220 million in liquidity. Despite some tenant-related challenges, it has preserved healthy cash flow and balance sheet strength. Its portfolio is diversified, and management remains focused on strategic sale-leasebacks.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

NewLake Capital Partners, Inc. (NLCP)

NewLake Capital Partners is a cannabis-focused REIT that invests in cultivation and retail properties. Established in 2019, the company has built a diverse portfolio of assets. It currently owns 33 properties across the U.S. These include 15 cultivation facilities and 18 retail dispensaries. The properties are spread across 12 states, including strongholds like Pennsylvania and Ohio.

NewLake’s tenants are major multi-state operators. Companies like Curaleaf and PharmaCann lease several of their facilities. The company operates under a triple-net lease structure. This ensures tenants handle all property expenses while NewLake collects fixed rent. As of May 2025, NewLake’s portfolio is fully leased, and occupancy remains strong.

Financially, NewLake posted $13.2 million in revenue for Q1 2025. This reflected a 4.8% year-over-year increase. Net income was $6.3 million, while adjusted funds from operations totaled $10.7 million. The company declared a $0.43 quarterly dividend, rewarding long-term investors. With over $100 million in available liquidity and a low debt ratio, NewLake is well-positioned for expansion. It has a reputation for responsible capital allocation and consistent rent collections. Management remains focused on adding new properties and deepening relationships with top-tier tenants.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Chicago Atlantic Real Estate Finance, Inc. (REFI)

Chicago Atlantic Real Estate Finance operates as a commercial mortgage REIT. Unlike IIPR and NLCP, it does not own physical properties. Instead, REFI provides secured loans to licensed cannabis operators. Its focus is on growth-stage companies with a strong operational history. The REIT specializes in senior secured loans, offering high-interest income and downside protection.

REFI’s portfolio includes 30 active loans totaling over $400 million. These loans are distributed across multiple states and sectors. Borrowers use funds for expansion, equipment, and facility improvements. The company works with experienced operators that meet strict underwriting criteria. This reduces credit risk and supports reliable income generation.

In Q1 2025, REFI reported net interest income of $13 million. Net income reached $10 million, or $0.47 per share. Operating expenses decreased, boosting overall profit margins. The company declared a quarterly dividend of $0.47 per share. This represents a high annualized yield, appealing to income investors. REFI also maintains access to a secured credit facility and holds strong liquidity. With its focus on short-duration loans and consistent underwriting, REFI remains a stable option in a volatile sector. It aims to scale its lending platform while preserving capital discipline.

Cannabis REITs Are Ideal for Long-Term Growth in 2025

Each of these cannabis REITs—Innovative Industrial Properties, NewLake Capital Partners, and Chicago Atlantic Real Estate Finance—brings a unique model to the table. IIPR focuses on real estate ownership and leasebacks. NLCP offers a diversified mix of retail and cultivation assets. REFI prioritizes high-yield lending with strong protections. All three demonstrate consistent revenue, strong dividends, and disciplined management. In a growing industry still underserved by traditional financing, these REITs continue to stand out. Investors seeking cannabis exposure with income stability should keep a close eye on these top-performing REITs in May 2025.

The post 2025’s Best Cannabis REITs for Building Wealth Over Time appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to surge, reaching an estimated $45 billion in 2025. Analysts expect it to grow to over $75 billion by 2030. With federal reform discussions advancing and legalization expanding, Canadian cannabis companies are positioning for growth. Many are making strategic moves to increase their U.S. exposure through acquisitions and partnerships.

This momentum has sparked investor interest in Canadian companies with operational ties to the U.S. These firms aim to capture future demand while waiting for federal legalization. This week, three stocks stand out: Tilray Brands Inc., Canopy Growth Corporation, and Village Farms International Inc. Each has taken bold steps to improve financial health and boost cross-border expansion. Let’s explore how these companies are performing and why they’re worth watching now.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Top Canadian Cannabis Stocks to Watch in May 2025

1. Tilray Brands Inc. (NASDAQ: TLRY)
2. Canopy Growth Corporation (NASDAQ: CGC)
3. Village Farms International Inc. (NASDAQ: VFF)

Tilray Brands Inc. (TLRY)

Tilray Brands Inc. is a diversified cannabis company with exposure to both wellness and beverage sectors. The company operates in Canada, Europe, and across the U.S. through THC-infused beverages and hemp-based products. In the U.S., Tilray distributes its THC drinks in over 10 states via various retail partnerships. Although it doesn’t own dispensaries, its beverages are stocked in liquor stores and convenience chains nationwide.

Tilray is also active in global markets. It has operations in Germany, Portugal, and Australia. These regions support both medical and recreational growth. Within North America, Tilray’s strategy focuses on consumer-packaged goods and market penetration through scalable partnerships. The company’s U.S. exposure continues to grow despite regulatory barriers.

In April 2025, Tilray reported its Q3 fiscal 2025 earnings. The company posted revenue of $185.8 million, slightly lower than last year. Gross profit rose 5% to $52 million. Gross margin improved to 28%, driven by cost controls and high-margin products.

Tilray’s cannabis segment delivered its strongest margin in two years. This result indicates progress in operational efficiency. However, the company posted a net loss of $793.5 million. This was mostly due to non-cash impairment charges that impacted reported earnings. Tilray also reduced its overall debt by $76 million. This move shows a commitment to long-term financial sustainability. Investors continue to monitor Tilray’s beverage expansion and cost-reduction initiatives for future performance.

[Read More] Top 3 Marijuana Stocks For Better Investing 2025

Canopy Growth Corporation (CGC)

Canopy Growth Corporation is one of the best-known cannabis producers in Canada. The company has multiple brands, including Tweed, Tokyo Smoke, and Martha Stewart CBD. Canopy has shifted its U.S. strategy through Canopy USA. This structure gives it exposure to American operators while complying with federal law.

Canopy USA controls stakes in several U.S. companies, including Wana, Jetty, and Acreage. These firms give Canopy access to edibles, vapes, and flower products. While Canopy cannot yet directly operate dispensaries in the U.S., this setup keeps it prepared for future legalization. The company’s brand portfolio remains one of its strongest assets.

In February 2025, Canopy reported its Q3 fiscal 2025 results. The company generated $74.8 million in revenue, a 5% drop from the prior year. However, revenue increased by 8% when excluding divested businesses. The company also reported a $24 million operating loss, but this marked a 61% improvement year-over-year.

Canopy’s medical cannabis business in Canada showed continued strength. International markets also contributed to stable revenue, especially in Europe. To improve its balance sheet, Canopy prepaid a $100 million loan. This will reduce interest costs and improve cash flow. Management continues to focus on operational efficiency and margin recovery. Investors are watching closely to see how U.S. political changes could impact Canopy’s expansion plans.

[Read More] Here Is How The Cannabis Industry Impacts The Public Sector

Village Farms International Inc. (VFF)

Village Farms International began as a greenhouse vegetable grower. It later pivoted into cannabis production through its Pure Sunfarms subsidiary. The company now operates as a vertically integrated cannabis and produce business. While Village Farms doesn’t yet own dispensaries in the U.S., it maintains agricultural operations in Texas and has plans for wellness-based expansion.

Pure Sunfarms is one of Canada’s most profitable cannabis producers. It is known for its cost efficiency and strong margins. Village Farms leverages its farming expertise to scale its cannabis operations. The company’s ability to manage multiple product lines gives it a unique position in the market.

On May 12, 2025, Village Farms reported its Q1 2025 earnings. Consolidated revenue came in at $77.1 million. This was slightly down from the $78.1 million posted a year earlier. However, its Canadian cannabis segment delivered a net income of $3 million. This was a 258% increase compared to the prior year.

Adjusted EBITDA for that segment grew by 64% to $6.7 million. These results highlight the strength of the company’s cannabis operations. Meanwhile, the produce segment continues to face weather-related challenges. To address this, Village Farms announced plans to privatize part of its produce business. This move allows the company to focus resources on higher-growth cannabis operations. Investors are optimistic that this shift will unlock more value in the quarters ahead.

Top Canadian Pot Stocks to Buy Before U.S. Federal Reform

Canadian cannabis companies are no longer just domestic players. Each of these three stocks—Tilray, Canopy, and Village Farms—offers a unique path into the growing U.S. market. They are actively restructuring operations, improving balance sheets, and expanding strategic footprints.

Tilray leads with beverages and CPG products. Canopy is leveraging brand strength and U.S. subsidiaries. Village Farms stands out with operational efficiency and profitability. All three companies have shown improvements in key financial metrics this year.

Still, cannabis remains a volatile sector. News, politics, and regulations can move these stocks quickly. As always, traders should use technical analysis and risk management strategies. Identify trend direction, volume changes, and support levels before making entries. Use stop losses to protect capital. Stay informed, stay flexible, and keep an eye on these leaders as the cannabis market heats up in 2025.

The post Best Canadian Marijuana Stocks for U.S. Market Exposure appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry is poised for continued growth in 2025. Market estimates suggest it could exceed $45 billion in total value this year. This growth is fueled by rising consumer demand and expanding access in newly legalized states. Recently, multiple states have advanced adult-use legislation, creating fresh momentum. As legalization efforts gain traction, more companies are entering the market. This trend provides new opportunities for investors focused on undervalued cannabis stocks. Many penny stocks in the sector are gaining attention due to strong volume and low price points. Therefore, marijuana penny stocks could offer explosive upside for short-term and long-term traders alike.

However, these stocks often come with heightened volatility. For this reason, technical analysis becomes essential. Traders should focus on support and resistance levels, trend confirmation, and trading volume. Additionally, proper risk management is critical. Always use stop-loss levels and size positions based on account risk. While potential gains can be substantial, downside moves can also be sharp. Consequently, disciplined strategies are key when trading marijuana penny stocks.

Marijuana Stocks With Breakout Charts

The U.S. cannabis sector continues to show long-term promise despite recent volatility. Several stocks are now catching the attention of traders and investors. This May, three companies stand out due to their size, recent expansion, and updated financial performance. These include The Cannabist Company, Cansortium Inc., and Verano Holdings. Each has made operational changes, opened new locations, or shifted strategy to gain market share.

As the industry evolves, picking stocks with strong fundamentals becomes more important. Regulatory news, consumer demand, and retail access will drive momentum. These three operators are expanding across high-growth states like Florida, Pennsylvania, and Illinois. With smart technical analysis and proper risk management, they may offer favorable setups. Now let’s look at each company in detail, starting with The Cannabist Company.

[Read More] Here Is How The Cannabis Industry Impacts The Public Sector

Top 3 Marijuana Stocks to Watch in May 2025

1. The Cannabist Company Holdings Inc. (OTC: CBSTF)
2. Cansortium Inc. (OTC: CNTMF)
3. Verano Holdings Corp. (OTC: VRNOF)

The Cannabist Company Holdings Inc. (CBSTF)

The Cannabist Company is one of the largest vertically integrated cannabis operators in the United States. Formerly known as Columbia Care, it runs dispensaries in 14 states. Its largest presence is in Florida, New York, and Virginia. The company operates 67 active dispensaries nationwide. In addition, it controls 17 cultivation and processing facilities.

The Cannabist retail brand offers a consistent experience across locations. It features premium cannabis products, including flower, vape cartridges, and capsules. The company owns and promotes in-house product lines such as Triple Seven and Seed & Strain. It aims to build customer loyalty through rewards and digital platforms. Recently, management has focused on streamlining operations and reducing costs. This includes closing underperforming dispensaries in mature markets.

Latest Financials

In its latest quarterly report, the company reported a slight decline in total revenue. Sales dropped due to pricing pressure and store closures. However, management has taken active steps to stabilize margins. This includes trimming SG&A expenses and exiting lower-margin states. Net loss improved compared to the prior year, showing better efficiency.

The company also restructured a significant portion of its outstanding debt. This reduces interest expenses and frees up cash for expansion. Gross profit margins improved as production costs fell in newer facilities. Overall, the balance sheet shows signs of recovery. If trends continue, revenue could stabilize by the second half of 2025. Investors are watching closely for guidance in the next earnings release.

[Read More] Investing in Green: Top U.S. Marijuana Stocks for May 2025

Cansortium Inc. (CNTMF)

Cansortium Inc., now doing business as Fluent, is a Florida-based cannabis company. It focuses on high-growth medical markets with strong consumer demand. The company’s largest presence is in Florida, where it operates over 30 dispensaries. It also has licenses in Texas, Pennsylvania, and New York. The Fluent brand emphasizes clean cultivation and pharmacist-led guidance.

Each Fluent location offers a wide selection of products, including tinctures, oils, vapes, and edibles. The company prides itself on professional service and clinical support. It continues to expand its cultivation capacity, targeting efficiency and quality. Plans include increasing canopy space and upgrading extraction capabilities. Florida remains the core growth engine, but expansion into Pennsylvania offers upside potential.

Latest Financials

Cansortium posted double-digit revenue growth year over year. The gains were driven mainly by Florida sales. Margins expanded as operating costs were held steady during the quarter. EBITDA also improved, thanks to higher average ticket prices and better product mix. The company remains cash flow positive and continues to pay down debt.

Capex has been controlled, with capital directed to proven markets. Management expects more growth from upcoming dispensary openings. Their financial forecast indicates rising revenue over the next two quarters. Key risks include regulatory delays and slower-than-expected market development in new regions. However, strong execution in Florida gives the company a firm foundation. Investors view this as one of the more stable micro-cap operators in the U.S.

[Read More] Top Marijuana Stocks With Upside Potential In The Market

Verano Holdings Corp. (VRNOF)

Verano Holdings is a major cannabis operator with a strong footprint across the U.S. Headquartered in Chicago, it is active in 13 states. Its largest market is Florida, where it now runs 81 dispensaries. The company also has a growing presence in New Jersey, Illinois, and Arizona. Its two key retail brands are Zen Leaf and MÜV.

Verano offers a full line of cannabis products, including flower, pre-rolls, vapes, and infused gummies. The company owns several in-house brands designed to appeal to different customer segments. These include Savvy, BITS, Avexia, and Encore. It has over 1 million square feet of cultivation space. The business is vertically integrated, giving it control over pricing, distribution, and supply chain. This helps maintain high product consistency across states.

Latest Financials

Verano reported annual revenue approaching $850 million last year. It remains one of the top earners in the cannabis sector. The company has faced recent net losses due to high operating costs and depreciation. However, adjusted EBITDA remains positive. Cost-cutting programs are underway to improve profitability. The Florida market has been especially strong, contributing a large share of total revenue.

New dispensaries continue to open on a monthly basis. The company forecasts further growth in adult-use states like New Jersey and Connecticut. It is also investing in automation to lower production costs. Debt levels are being managed carefully, and liquidity appears stable. Analysts are looking for signs of margin recovery in upcoming quarters. Long-term, Verano is viewed as a potential consolidator in the U.S. market.

[Read More] High Potential: Canadian Cannabis Stocks Making Waves in May 2025

Top Pot Penny Stocks to Watch Closely in May 2025

The cannabis industry remains volatile but filled with opportunity. Companies with strong fundamentals and multistate operations are best positioned for the future. The Cannabist Company, Cansortium Inc., and Verano Holdings all meet those criteria. Each is expanding in high-demand states and actively improving financials. With careful chart analysis and smart entry points, these stocks could offer attractive setups in May 2025

The post Best Cannabis Penny Stocks for Your May 2025 Trading Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to grow rapidly. Experts predict it could contribute over $120 billion to the national economy in 2025. This surge is fueled by increasing demand, expanding legalization, and broader acceptance. Currently, over 20 states have legalized recreational marijuana, and more are exploring similar moves. Recent headlines point to bipartisan efforts in several states pushing for full legalization. As regulations shift, investor interest in cannabis stocks continues to rise. Among them, marijuana penny stocks are gaining momentum due to their high-risk, high-reward nature. These low-priced shares often react sharply to news, market sentiment, and legislative developments. Therefore, they offer unique opportunities for traders looking for volatility and upside. However, not every stock is worth the risk. Identifying quality companies is essential. Timing also matters. That’s where strategy and analysis come in. Let’s explore how to approach these stocks wisely.

Marijuana penny stocks can move fast, so preparation is key. Traders should rely on technical analysis to guide decisions. Tools like moving averages, RSI, and volume spikes help confirm trends and potential breakouts. Support and resistance levels also offer crucial insight. However, strategy means little without discipline. Using stop-loss orders can prevent large drawdowns. Managing position sizes also helps limit risk exposure. Many penny stocks trade on low volume, so entry and exit timing become even more important. Additionally, it’s wise to watch overall market sentiment. Cannabis stocks tend to follow broad sector momentum. When volume surges and catalysts align, breakouts can be explosive. But sharp pullbacks are also common. Therefore, staying nimble is essential. Focused watchlists and clear trade plans can offer an edge. With the right setup and discipline, marijuana penny stocks can offer compelling opportunities this week.

[Read More] Top Marijuana Stocks With Upside Potential In The Market

U.S. Marijuana Stocks Showing Strong Performance

The U.S. cannabis sector remains one of the fastest-growing industries despite recent volatility. In May 2025, several leading operators are drawing attention from investors. Regulatory momentum continues to build, and many companies are positioning for long-term growth. With improving margins and tighter cost controls, top multi-state operators are starting to stand out.

Three U.S. marijuana stocks with solid fundamentals and strong retail footprints include AYR Wellness, Cresco Labs, and Curaleaf Holdings. Each company is advancing its market share while reducing expenses and boosting cash flow. As traders seek quality setups, these stocks offer compelling potential based on technical and fundamental factors. However, risk management and timing remain essential. Let’s take a closer look at each of these leading cannabis operators.

Top-Performing U.S. Marijuana Stocks to Watch in May 2025

1. AYR Wellness Inc. (OTC: AYRWF)
2. Cresco Labs Inc. (OTC: CRLBF)
3. Curaleaf Holdings Inc. (OTC: CURLF)

AYR Wellness Inc. (AYRWF)

AYR Wellness is a vertically integrated cannabis company with a focus on medical and adult-use markets. The company operates across eight U.S. states. Its largest presence is in Florida, where it has over 60 dispensaries. In total, AYR operates 97 retail locations, with a growing footprint in Ohio and Pennsylvania. The company also has operations in Massachusetts, New Jersey, and Connecticut. Recently, it gained approval to enter Virginia with a full vertical license. This strategic expansion supports its long-term growth objectives.

AYR focuses on disciplined spending and operational efficiency. It has also invested in cultivation, particularly in Florida. A large indoor facility is currently under development. This will improve consistency and supply chain flexibility. Despite competition, AYR continues to open new locations in key markets. It aims to build strong regional leadership in each state it operates. This focus on footprint quality over size has become a core part of its strategy.

In its latest quarterly report, AYR posted revenue of $114 million, which marked consistent sequential growth. Adjusted gross margins came in at 49%, reflecting improved operational execution. AYR generated $9.6 million in cash flow from operations during the quarter, helping it finish the year with $35.5 million in cash. Capital expenditures were limited to $17.7 million for the full year, which was well below initial guidance.

The company also completed several debt restructurings. These efforts pushed major maturities to 2026 and reduced near-term financial pressure. AYR’s EBITDA for the quarter came in at $19.1 million. This demonstrated early success in stabilizing margins and improving cash flow. Despite macro headwinds, management expects steady performance in the year ahead. Their focus will remain on profitable growth and cost control.

[Read More] High Potential: Canadian Cannabis Stocks Making Waves in May 2025

Cresco Labs Inc. (CRLBF)

Cresco Labs is a leading multi-state cannabis operator with a broad retail and wholesale presence. The company is well known for its Sunnyside dispensary brand. It operates across several large cannabis markets, including Illinois, Pennsylvania, and Massachusetts. Cresco holds the number one market share in multiple states. The company currently runs over 60 dispensaries nationwide. It also maintains one of the largest branded product portfolios in the cannabis space.

Cresco focuses heavily on compliance, quality, and consumer trust. Its retail strategy is patient-focused, offering personalized service and premium experiences. The company also maintains cultivation and processing facilities in each state it operates. Recently, it expanded cultivation in Pennsylvania and added operations in new medical markets. These efforts support both wholesale distribution and in-house retail supply.

In 2024, Cresco reported $724 million in revenue. While this marked a 6% decline year-over-year, profitability improved. The company generated $364 million in gross profit and $200 million in adjusted EBITDA. This represented a 15% increase from the previous year. Operating cash flow came in at a record $132 million. This was a 126% increase from 2023. Cresco attributed the gain to better expense management and margin expansion.

Free cash flow was positive as well, further improving the company’s balance sheet. Inventory controls and disciplined capital allocation drove better financial outcomes. Management noted significant improvements in pricing discipline and cost per gram. These metrics continue to support future profitability. With strong brand loyalty and operational scale, Cresco remains well-positioned for continued expansion in 2025. Analysts expect it to maintain top-tier margins across core markets.

[Read More] Best Cannabis Penny Stocks to Add to Your May 2025 Watchlist

Curaleaf Holdings Inc. (CURLF)

Curaleaf Holdings is the largest cannabis operator in the U.S. by revenue and dispensary count. It currently operates 151 retail locations across 17 states. Its largest concentration is in Florida, where it runs 66 dispensaries. The company also has a growing international footprint, with recent product launches in Europe. In the U.S., Curaleaf has focused on high-volume markets and scale efficiencies. Its rebranding initiatives in Nevada and infrastructure upgrades highlight its evolving retail strategy.

Curaleaf is known for its wide selection of products and broad distribution. It serves both medical and recreational consumers. Its stores are designed for high traffic and convenience, driving repeat business. The company also emphasizes digital ordering and loyalty programs. These tools support customer retention and higher basket sizes. In addition to its dispensaries, Curaleaf operates several processing and cultivation sites across the country.

In 2024, Curaleaf generated $1.34 billion in revenue. This marked one of the highest totals in the U.S. cannabis sector. Gross profit for the year reached $639.2 million, with adjusted EBITDA of $300.8 million. The company produced $163.3 million in operating cash flow and $70.1 million in free cash flow. Despite a net loss of $216.2 million, management expressed confidence in its financial path forward.

Key growth drivers include vertical integration, brand expansion, and margin improvement. The company also refinanced certain credit facilities to enhance liquidity. In 2025, Curaleaf will focus on organic growth through its “Return to Our ROOTS” plan. This includes store-level optimization, margin expansion, and strategic debt reduction. Overall, Curaleaf’s scale and diversification offer strong long-term upside as legalization momentum builds.

These three cannabis stocks continue to separate themselves from weaker players in the space. With operational discipline, expanding retail footprints, and improving financials, AYRWF, CRLBF, and CURLF deserve a place on every marijuana investor’s watchlist in May 2025.

The post Investing in Green: Top U.S. Marijuana Stocks for May 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to gain momentum as more states legalize marijuana for recreational and medical use. As of this week, over 20 states now allow adult-use cannabis, and more states are actively exploring legislation. The market is expected to reach over $45 billion in total value by 2025. This sustained growth creates new opportunities for investors looking to enter the space. Recently, there has been renewed discussion about federal reform. Lawmakers are revisiting cannabis rescheduling and expanding access to banking for cannabis businesses. These headlines have sparked renewed interest in marijuana stocks. As a result, traders are now watching several U.S. cannabis companies that could benefit from regulatory momentum.

However, identifying strong opportunities requires more than reading the news. Technical analysis is essential when evaluating short-term entries in volatile sectors like cannabis. Traders should look for patterns, volume spikes, and key support levels. It’s also critical to use proper risk management. Stop losses, trade sizing, and clear entry targets can help limit downside. Even the strongest chart setup can fail without discipline. As the week unfolds, combining these strategies with a solid watchlist may help traders stay focused and avoid emotional decision-making.

In May 2025, investors will continue searching for companies with strong growth potential, strategic positioning, and improving financials. Three marijuana stocks stand out this month: Glass House Brands Inc. (GLASF), The Cannabist Company Holdings Inc. (CBSTF), and Ascend Wellness Holdings Inc. (AAWH). Each company brings unique strengths to the table, including strong retail footprints, cultivation capabilities, and innovative branding. Below is a detailed breakdown of each company’s market presence and financial performance.

[Read  More]  Best Cannabis Penny Stocks to Add to Your May 2025 Watchlist

Top U.S. Marijuana Stocks to Watch in May 2025

1. Glass House Brands Inc. (OTC: GLASF)
2. The Cannabist Company Holdings Inc. (OTC: CBSTF)
3. Ascend Wellness Holdings Inc. (OTC: AAWH)

Glass House Brands Inc. (GLASF)

Glass House Brands Inc. is a vertically integrated cannabis company based in California. The company owns and operates several dispensaries across the state under various banners, including The Farmacy and Natural Healing Center. One of its most notable assets is a massive greenhouse cultivation facility located in Ventura County. This facility is among the largest in the United States, spanning over five million square feet. The company uses this facility to produce high-quality cannabis at scale.

Currently, Glass House operates more than a dozen dispensaries across California. The company’s primary focus remains on the California adult-use market, where it sees significant long-term opportunity. By combining large-scale cultivation with branded retail outlets, Glass House continues to build its presence in one of the most competitive cannabis markets in the U.S. Additionally, its retail strategy includes premium positioning and community-focused stores that appeal to both newcomers and experienced users.

Financially, Glass House has made considerable progress. In recent quarters, the company posted year-over-year revenue growth, driven by an increase in both wholesale and retail sales. The company has also focused on reducing its cost per pound of production. By operating its large-scale greenhouse efficiently, it has improved margins significantly. This focus on cost control has helped the company generate positive adjusted EBITDA in recent quarters.

Additionally, Glass House expects continued growth throughout 2025. Management has projected increased output from its cultivation facility and additional store openings. These developments are expected to drive revenue to new highs. The company is also investing in branded product lines, which offer higher margins and stronger customer loyalty. Despite challenges in the California market, Glass House remains well-positioned due to its scale and brand strength.

[Read More] Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025

The Cannabist Company Holdings Inc. (CBSTF)

The Cannabist Company Holdings Inc., formerly known as Columbia Care, is a multi-state operator with a wide footprint across the U.S. The company operates dispensaries under the Cannabist brand in both medical and adult-use markets. It is currently active in 14 states and manages nearly 100 facilities. This includes more than 70 dispensaries and over 20 cultivation and processing centers. The Cannabist brand aims to deliver a premium cannabis experience to consumers through innovative retail design and curated product offerings.

The company’s largest presence includes states like Florida, New York, and Virginia. It serves both medical patients and recreational customers with a broad selection of flower, edibles, tinctures, and concentrates. Additionally, it owns and distributes several in-house brands. These include Seed & Strain, Triple Seven, and Hedy, each targeting different consumer segments. Through its wide reach and vertical integration, the Cannabist Company seeks to maximize efficiencies and build brand recognition nationwide.

On the financial side, the company has faced some recent headwinds. Revenue saw a modest decline year-over-year due to regulatory delays and pricing pressure in several markets. However, the company has taken action to improve its balance sheet. Management has focused on debt restructuring and improving operational efficiencies. The extension of certain credit terms has allowed the company to reduce financial pressure and plan more effectively for long-term growth.

Although margins tightened slightly in 2024, cost-cutting measures and better inventory management have helped stabilize earnings. Additionally, management is targeting future profitability through improved dispensary performance and streamlined operations. As new adult-use markets open and regulations ease, the Cannabist Company may be well-positioned to regain revenue momentum. It remains a stock to watch closely, especially if broader cannabis reform gains traction at the federal level.

[Read More] 3 Marijuana Stocks For The Long-Term Investing

Ascend Wellness Holdings Inc. (AAWH)

Ascend Wellness Holdings Inc. is another top-tier cannabis operator with a strong footprint in limited-license states. The company operates in seven states: Illinois, Massachusetts, Michigan, New Jersey, Ohio, Pennsylvania, and Maryland. Ascend owns and operates cultivation facilities, processing centers, and over 30 retail dispensaries across these markets. The company is known for its vertically integrated structure and diverse product portfolio, which includes edibles, concentrates, flower, and vapes.

Ascend’s retail strategy focuses on high-traffic locations and premium store layouts. The company’s in-house brands include Ozone and Simply Herb. These brands cater to both value-conscious customers and those seeking premium products. Ascend also has a strong wholesale operation, supplying products to third-party dispensaries in addition to its own stores. The company’s strategic positioning in high-growth, tightly regulated markets gives it a competitive edge.

From a financial perspective, Ascend has delivered consistent top-line growth. In 2024, the company posted an annual revenue increase compared to the prior year. This growth was supported by new store openings and increased cultivation yields. However, like many cannabis operators, Ascend reported a net loss as it continued to invest in infrastructure and expansion. Despite this, management emphasized a strong focus on achieving profitability through margin improvements and operating leverage.

The company also initiated a share repurchase program in late 2024. This was seen as a sign of management’s confidence in long-term value creation. In 2025, Ascend is expected to continue expanding in New Jersey and Maryland, where adult-use markets are gaining traction. These expansions could significantly boost revenue and brand visibility. With disciplined growth and operational improvements underway, Ascend remains a strong candidate for long-term investors in the cannabis sector.

[Read More] These 3 Marijuana Stocks Could Be The Winners You Need

Capitalizing on Cannabis Gains: Investment Approaches Post-Upside

As the U.S. marijuana industry matures, companies with strong fundamentals and strategic market positions are beginning to emerge as clear leaders. Glass House Brands, The Cannabist Company, and Ascend Wellness each offer a different path to growth. Whether through large-scale cultivation, nationwide branding, or disciplined state expansion, these companies are positioned to capitalize on the evolving regulatory and consumer landscape. For investors looking at cannabis exposure in May 2025, these three stocks are well worth a spot on the watchlist.

The post Cannabis Stocks on the Rise: Key Players to Watch Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to expand, driven by rising demand and broader state-level legalization. By the end of 2025, analysts expect the market to exceed $45 billion in value. Currently, adult-use cannabis is legal in nearly half of the U.S. states. This trend fuels investor interest, especially in marijuana penny stocks. These low-priced equities offer high-risk, high-reward opportunities. Because of their affordability, they attract retail traders seeking large percentage gains. As legalization advances, more small-cap cannabis firms are positioned for explosive growth. Therefore, keeping these stocks on a weekly watchlist is a smart move for active traders.

However, it’s essential to apply disciplined strategies. Marijuana penny stocks are highly volatile and can change direction quickly. Technical analysis helps traders identify support and resistance levels. It also highlights potential breakout patterns and price reversals. Just as important, risk management protects capital. Traders should use stop-loss orders and avoid overexposure. With proper strategy and timing, these stocks can present compelling short-term opportunities.

Here are three top marijuana stocks to watch in May 2025: Planet 13 Holdings (PLNH), FLUENT Corp. (formerly Cansortium, CNTMF), and Ayr Wellness (AYRWF). Each company has a significant presence in the U.S. cannabis market and has shown notable developments in recent financials.

[Read More] The Best Marijuana To Make Potential Profits In 2025

Weekly Watchlist: Promising Marijuana Penny Stocks with Breakout Potential

1. Planet 13 Holdings (OTC: PLNH)
2. FLUENT Corp. (formerly Cansortium, OTC: CNTMF)
3. Ayr Wellness (OTC: AYRWF)

Planet 13 Holdings (PLNH)

Planet 13 Holdings is a vertically integrated cannabis company headquartered in Las Vegas, Nevada. It operates the world’s largest dispensary, located just off the Las Vegas Strip. In addition to its flagship location, Planet 13 has expanded its footprint across several states. As of April 2025, the company operates 37 dispensaries nationwide, including 33 in Florida. This expansion into Florida has been a significant growth driver for the company.

Latest Financials

In Q4 2024, Planet 13 reported revenue of $30.3 million, marking a 31.8% increase year-over-year. This growth was primarily driven by the company’s expansion in Florida. However, the company faced challenges with a net loss of $26.4 million, which included an $18.9 million non-cash impairment loss. The gross profit for the quarter was $13.1 million, representing a margin of 43.2%, down from 47.8% in the previous year. The decline in gross margin was attributed to industry-wide price compression and targeted discounting in Florida. Despite these challenges, Planet 13’s expansion strategy and strong presence in key markets position it as a notable player in the cannabis industry.

[Read More] Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025

FLUENT Corp. (formerly Cansortium, CNTMF)

FLUENT Corp., previously known as Cansortium Inc., is a multi-state cannabis operator based in Tampa, Florida. The company operates under the FLUENT brand and has a significant presence in Florida, Texas, Pennsylvania, and New York. As of early 2025, FLUENT has expanded its operations through the acquisition of RIV Capital, adding New York retail, wholesale, and cultivation operations to its portfolio. This strategic move has enhanced FLUENT’s footprint in the U.S. cannabis market.

Latest Financials

In 2024, FLUENT reported annual revenue of $103.6 million, reflecting a 6.4% year-over-year increase. The company’s Q4 2024 revenue was $24.9 million, a slight decrease compared to the previous year. Florida operations contributed significantly, with revenue at $20.3 million. Adjusted gross profit for the quarter was $10.0 million, representing 40.1% of revenue. Adjusted EBITDA stood at $3.0 million, driven by higher sales in Florida. FLUENT’s strategic acquisitions and consistent financial performance make it a noteworthy company in the cannabis sector.

[Read More] April 2025 Ancillary Cannabis Stock Watchlist: Three Companies Powering the Industry

Ayr Wellness (AYRWF)

Ayr Wellness is a vertically integrated, multi-state cannabis operator headquartered in Miami, Florida. The company operates over 90 licensed dispensaries across eight states, including Florida, Pennsylvania, and New Jersey. Ayr has been focusing on expanding its retail footprint and enhancing its product offerings to cater to a diverse customer base.

Latest Financials

For the full year 2024, Ayr Wellness reported generating $9.6 million in cash flow from operations. The company ended the year with a cash balance of $35.5 million, down from $50.6 million at the end of Q3 2024. In addition, Ayr secured $30 million in financing for a new Florida cultivation facility and successfully deferred $400 million in debt maturity to 2026. Despite revenue headwinds, Ayr’s strategic financial decisions and expansion efforts position it as a significant player in the cannabis industry.

Top Undervalued Cannabis Penny Stocks for Technical Traders

These companies—Planet 13 Holdings, FLUENT Corp., and Ayr Wellness—have demonstrated significant developments in their operations and financials, making them noteworthy stocks to watch in the cannabis sector for May 2025.

The post Best Cannabis Penny Stocks to Add to Your May 2025 Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues expanding rapidly, with projections suggesting it could reach $45 billion by 2025. More states are legalizing cannabis for medical and recreational use, boosting demand across the nation. Currently, 24 states allow adult-use cannabis, supporting thousands of dispensaries and grow operations. Additionally, the industry provides over 440,000 full-time jobs, strengthening its economic importance. Meanwhile, recent developments in federal policy signal possible changes ahead. Lawmakers are pushing for cannabis reform, and discussions around federal reclassification have gained momentum. As a result, investor interest is rising steadily, especially in real estate tied to cannabis operations. However, navigating this evolving market requires careful attention and research. Therefore, focusing on cannabis REITs with proven portfolios and strong tenants remains a smart strategy. In particular, companies that operate across multiple states offer added stability and diversification.

Given the industry’s volatility, investors must also use technical analysis when trading cannabis REITs. Watching price trends, volume shifts, and key support levels is crucial for success. Furthermore, setting clear risk management rules helps protect capital during uncertain periods. Stop losses, position sizing, and realistic targets should be part of every trade plan. This disciplined approach allows investors to handle price swings with more confidence. Meanwhile, staying updated on legalization headlines ensures you are not blindsided by regulatory news. Today’s top cannabis REITs combine steady financials with long-term growth potential. Innovative Industrial Properties, Chicago Atlantic Real Estate Finance, and NewLake Capital Partners all offer strong opportunities this week. Their diversified exposure to cultivation and retail properties gives them important advantages. As momentum builds across the cannabis sector, these REITs stand ready to capitalize on expanding demand.

Cannabis REIT Stocks Offering Strong Dividends and Growth Potential

As the cannabis industry expands, real estate investment trusts (REITs) are playing a growing role in its infrastructure. These specialized REITs lease properties to cannabis operators, providing vital capital and stability. In April 2025, three cannabis REITs are showing strong fundamentals and strategic growth. These include Innovative Industrial Properties (IIPR), Chicago Atlantic Real Estate Finance (REFI), and NewLake Capital Partners (NLCP). Each REIT operates differently, but all are positioned to benefit from the sector’s continued growth and regulatory momentum.

[Read More] These 3 Marijuana Stocks Could Be The Winners You Need

Top 3 Cannabis REITs to Watch in April 2025

1. Innovative Industrial Properties, Inc. (NYSE: IIPR)
2. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI)
3. NewLake Capital Partners, Inc. (OTC: NLCP)

Innovative Industrial Properties, Inc. (IIPR)

Innovative Industrial Properties is the most recognized name in cannabis real estate. The company owns and leases properties to licensed operators. IIPR’s focus is on cultivation and processing facilities across legalized U.S. states. As of April 2025, IIPR holds a portfolio of 109 properties in 19 states. The largest concentration of assets is in Pennsylvania, a key medical market. These properties are mission-critical for operators, making IIPR an essential player. The company signs long-term, triple-net leases, ensuring consistent rental income. Its tenants include several multistate operators with a national footprint. Because of this, IIPR has become a preferred landlord in the cannabis space. Its structure offers exposure to the industry with reduced operational risk. As legalization efforts expand, IIPR’s model becomes even more relevant.

Financially, IIPR remains strong. In the most recent full-year report, total revenue exceeded $300 million. Net income was solid, driven by stable lease payments and renewals. The company maintained a conservative debt profile, which supports long-term sustainability. Dividends have remained consistent and generous, rewarding shareholders. The payout ratio is healthy, which reflects disciplined cash flow management. IIPR’s quarterly dividend was recently increased, showing confidence in future earnings. Moreover, occupancy rates across its portfolio remain near 100%. Despite market fluctuations, IIPR continues to deliver strong financial performance. This combination of reliable income and exposure to a growing sector makes IIPR a compelling REIT to watch this month.

[Read More] April 2025 Ancillary Cannabis Stock Watchlist: Three Companies Powering the Industry

Chicago Atlantic Real Estate Finance, Inc. (REFI)

Chicago Atlantic Real Estate Finance is a commercial mortgage REIT serving the cannabis industry. The firm provides capital through senior secured loans. These loans support licensed cannabis companies seeking to expand or acquire real estate. REFI does not own dispensaries or grow operations itself. Instead, it earns income through interest payments on its loan portfolio. This makes REFI a financial backbone for cannabis expansion. Based in Chicago, the company focuses on underserved areas in need of funding. Its borrowers often include vertically integrated operators with limited access to traditional banking. Because cannabis remains federally illegal, REFI fills a critical financing gap. The company’s loan book is diversified across multiple states. It emphasizes risk control by targeting high-quality borrowers and conservative loan-to-value ratios. As a result, it has built a reputation for disciplined underwriting.

REFI’s financials continue to reflect strong execution. Total investment income has steadily increased year over year. Net interest income remains healthy, driven by rising yields and disciplined loan management. The company keeps operating costs low, which improves overall profitability. REFI also maintains minimal non-performing loans, showing effective risk oversight. In its latest quarter, REFI declared a steady cash dividend. The dividend yield remains attractive for income-focused investors. Earnings have comfortably covered the dividend, reinforcing the REIT’s financial strength. REFI’s performance is not reliant on real estate appreciation. Instead, it benefits from the demand for capital within the cannabis space. With its consistent returns and focused lending strategy, REFI is a strong REIT to watch. It offers exposure to cannabis growth without the operational volatility seen in other sectors.

[Read More] Top U.S. Pot Stocks for Growth in April 2025

NewLake Capital Partners, Inc. (NLCP)

NewLake Capital Partners is a cannabis-focused REIT that owns cultivation and retail properties. Headquartered in Connecticut, NLCP has a diverse property portfolio. As of April 2025, it owns 32 properties across 12 states. The company’s tenants are licensed operators in both medical and recreational markets. Pennsylvania is currently its most concentrated state. NLCP leases real estate to operators like Curaleaf, among others. These leases are long-term and often include built-in rent escalations. The properties include both dispensaries and grow facilities. This dual exposure gives NLCP a balanced revenue stream. The company uses sale-leaseback transactions to fund growth. This allows operators to raise capital while securing long-term space. NLCP’s strategy emphasizes tenant quality and conservative deal structures. The company’s flexible capital deployment supports continued expansion.

On the financial side, NLCP is showing steady growth. Revenue has increased year over year due to higher occupancy and added properties. Net income continues to rise, supported by disciplined spending and strong rental payments. The REIT has kept debt levels manageable, which protects against interest rate pressure. Dividend payouts remain consistent and competitive. In the latest quarter, NLCP distributed a regular dividend to shareholders. The payout has remained stable despite broader sector volatility. Its balance sheet remains healthy, with solid cash reserves and limited exposure to troubled tenants. NLCP is also evaluating new acquisition opportunities in emerging markets. As legalization trends advance, the company could benefit from new state entries. Overall, NLCP’s blend of operational focus and financial stability makes it a smart REIT to monitor this April.

Cannabis REITs With Strong Dividends and Promising Long-Term Growth

These three cannabis REITs each offer different ways to invest in the cannabis real estate market. IIPR focuses on property ownership and leasing to major operators. REFI offers financing through secured lending, avoiding real estate volatility. NLCP provides a hybrid model of retail and cultivation leasing with a stable tenant base. All three demonstrate strong financials and consistent dividend payouts. As the cannabis sector evolves, these REITs remain well-positioned. They balance growth with risk management, making them attractive for both conservative and growth-oriented investors. April 2025 could present new opportunities as more states expand cannabis programs. These REITs are ready to meet that demand.

The post Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry is expanding rapidly, with projections suggesting it could surpass $75 billion in value by 2030. This growth is fueled by rising consumer demand, expanding legalization, and increased acceptance of medical cannabis. Recently, lawmakers introduced new legislation that could pave the way for federal cannabis reform. This has reignited investor interest in marijuana-related stocks, especially low-cost options. As the regulatory environment evolves, these penny stocks are drawing attention for their high-reward potential.

Marijuana penny stocks typically trade below $5 per share. They can offer fast gains but also carry elevated risks. Therefore, technical analysis becomes essential. Tools like moving averages and RSI help identify momentum shifts. Traders also watch support and resistance zones for trade setups. Risk management is equally important. Setting stop-loss orders and position sizing are key to protecting capital. In this fast-moving sector, staying disciplined can help turn volatility into opportunity.

The U.S. cannabis industry is expanding rapidly as legalization efforts continue. Investors are turning their attention to marijuana stocks showing strong fundamentals and operational growth. In April 2025, three standout companies include Glass House Brands Inc. (GLASF), Cansortium Inc. (CNTMF), and Ascend Wellness Holdings Inc. (AAWH). Each company offers strategic advantages, growing footprints, and compelling financial stories. With demand for cannabis increasing and regulatory reform underway, these stocks deserve a closer look.

[Read More] 2 Marijuana Stocks To Consider For Long-Term Investing

Top 3 Marijuana Stocks to Watch in April 2025

1. Glass House Brands Inc. (OTC: GLASF)
2. Cansortium Inc. (OTC: CNTMF)
3. Ascend Wellness Holdings Inc. (OTC: AAWH)

Glass House Brands Inc. (GLASF)

Glass House Brands is based in California and focuses on cultivating, manufacturing, and distributing cannabis products. It has become one of the largest vertically integrated cannabis companies in the state. The company emphasizes sustainable, environmentally friendly growing techniques. It owns one of the largest greenhouse operations dedicated to cannabis cultivation in the U.S.

As of April 2025, Glass House operates five dispensaries across California. These locations include cities like Los Angeles, Santa Barbara, and Berkeley. The company targets both wholesale and retail segments, supplying dispensaries and direct consumers alike. Its strong presence in California gives it access to the country’s largest legal cannabis market.

Financially, Glass House continues to show year-over-year growth. In 2024, it significantly increased biomass output, helping drive higher revenue. It projects biomass production to increase by over 25% this year. Additionally, full-year revenue is expected to grow by more than 10%.

Adjusted EBITDA nearly doubled in the most recent quarter. Profit margins also improved due to cost reductions and operational efficiencies. Overall, the company is on track for a profitable year, driven by strategic expansion and production scale. Investors see Glass House as a dominant California brand with national growth potential.

[Read More] April 2025’s Canadian Cannabis Stock Picks: Growth and Opportunity

Cansortium Inc. (CNTMF)

Cansortium Inc. operates under the brand name FLUENT. It is a vertically integrated cannabis company focused on quality cultivation and retail services. The company is headquartered in Miami, Florida, and serves several key U.S. markets. Cansortium is known for its medical cannabis operations and dedication to customer experience.

Its largest footprint is in Florida, where it runs dozens of dispensaries. Additional operations extend into Pennsylvania and Texas. The company focuses on creating consistent, premium cannabis products. As of April 2025, it manages 28 dispensary locations across the country.

Cansortium’s financial performance reflects its disciplined approach. The company has maintained stable operations despite pricing pressures in Florida. While its stock price remains below one dollar, it continues to attract attention for long-term growth. Cost controls and streamlined operations have helped reduce cash burn.

Though revenue has remained relatively flat, gross margins have shown improvement. The company remains committed to profitability, even in a challenging environment. By focusing on core markets and operational efficiency, Cansortium aims to return to growth in the second half of the year.

[Read More] Top Ancillary Marijuana Stocks For The Diversified Investors

Ascend Wellness Holdings Inc. (AAWH)

Ascend Wellness is a multi-state operator with assets across several eastern U.S. states. The company is based in New York and holds cultivation, processing, and retail licenses. Its markets include Illinois, Michigan, New Jersey, Massachusetts, Ohio, and Pennsylvania. Ascend targets both adult-use and medical cannabis consumers.

The company currently operates 35 dispensaries and seven cultivation facilities. It has established a strong brand in states like Illinois and New Jersey. Ascend’s vertically integrated model supports supply chain control and higher profit margins. Its premium product lines are sold across retail and wholesale channels.

In 2024, Ascend posted strong financials. Total annual revenue increased to over $560 million, driven by wholesale growth. Third-party wholesale sales surged nearly 30%, supporting top-line expansion. Retail sales held steady, despite market saturation in some states.

Adjusted gross profit reached over $225 million, with margins improving year-over-year. The company ended the year with nearly $90 million in cash, giving it flexibility for future investments. Ascend continues to optimize operations while expanding its geographic footprint. It remains well-positioned for further growth in 2025 and beyond.

Undervalued Cannabis Stocks Ready to Rebound

To begin with, these three companies—Glass House Brands, Cansortium, and Ascend Wellness—each offer a unique value proposition in the evolving cannabis sector. Moreover, their strong operational strategies, expanding footprints, and disciplined financials make them top marijuana stocks to watch in April 2025. As a result, they are well-positioned to benefit from renewed momentum in the industry. Looking ahead, as investor interest returns to cannabis, these names could very well lead the next wave of growth.

The post Top U.S. Pot Stocks for Growth in April 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

As the U.S. cannabis industry continues to grow, Canadian cannabis stocks are gaining momentum with investors. The U.S. market is expected to reach over $44 billion in 2025. By 2030, analysts believe it could climb to more than $75 billion. Adult-use cannabis is now legal in nearly half of the U.S. states. Many others permit medical use, creating widespread demand. At the same time, lawmakers are again discussing federal reform bills. These bills aim to provide national guidelines and unlock interstate trade. Although legalization has faced delays, investor sentiment remains optimistic. Canadian companies are preparing to scale their U.S. operations once laws change.

For those watching cannabis stocks, technical analysis and strong risk management are essential. Traders should track price levels, trend strength, and buying volume. Support and resistance zones can guide entry and exit decisions. Meanwhile, risk management helps prevent emotional trading and limits downside exposure. As the sector remains volatile, discipline is key. With careful planning, investors can position for future upside while protecting capital.

Investors are increasingly watching these firms for their strategic U.S. expansions, unique product lines, and financial recovery efforts. Tilray Brands (TLRY), Canopy Growth Corporation (CGC), and Village Farms International (VFF) are three top Canadian cannabis stocks showing potential in April 2025. Despite ongoing regulatory hurdles, each has developed a growing footprint in the American market. Let’s break down where each company stands and how its financials are shaping up.

[Read More] Top Ancillary Marijuana Stocks For The Diversified Investors

Top 3 Canadian Cannabis Stocks to Watch in April 2025

Tilray Brands (NASDAQ: TLRY)

Canopy Growth Corporation (NASDAQ: CGC)

Village Farms International (NASDAQ: VFF)

Tilray Brands (TLRY)

Tilray Brands remains one of Canada’s most well-known cannabis companies. It operates in the cannabis, hemp, and craft beverage sectors. Although Tilray is headquartered in Canada, it has carved out a strong presence in the U.S. through acquisitions. These include SweetWater Brewing and Manitoba Harvest, which distribute across many U.S. states. As of now, Tilray does not run any dispensaries in the United States. Instead, it uses indirect methods to expand reach, such as beverages and hemp-based wellness products. This allows Tilray to build brand familiarity while awaiting full federal legalization. Additionally, Tilray is positioning itself for fast entry once regulatory barriers are lifted. These strategic moves help it stay competitive and build U.S. infrastructure ahead of time.

Latest Financials

In its most recent quarter, Tilray reported net revenue of approximately $186 million. This figure slightly decreased compared to last year’s same quarter. However, gross profit rose year-over-year to just over $52 million. Tilray’s cannabis business contributed about 29% of the total revenue. Beverage products—like THC-free craft beer—contributed a similar share. The company still posted a significant quarterly loss, largely due to non-cash impairment charges. Tilray continues to focus on restructuring costs and optimizing operations. It remains committed to growing revenue through high-margin segments. The path to profitability may be long, but Tilray appears determined to stabilize and scale up across both North American and global markets.

[Read More] Best Cannabis Infrastructure Stocks to Buy in 2025

Canopy Growth Corporation (CGC)

Canopy Growth has gone through multiple transitions in recent years. It is now shifting its focus toward U.S. cannabis expansion. The company owns recognizable brands such as Tweed and 7ACRES. However, Canopy has made bigger waves through U.S. acquisitions. These include Acreage Holdings, Wana Brands, and Jetty Extracts. These moves give Canopy a foothold in several states, including New York, New Jersey, and Illinois. Through Acreage, Canopy gains access to a dispensary network and cultivation licenses. Although full control remains conditional on U.S. federal reform, Canopy has positioned itself as a first-mover. This strategy allows it to build value while waiting for regulatory green lights. The company also has a wellness and vape presence in various U.S. markets.

Latest Financials

For the latest quarter, Canopy Growth reported around $75 million in net revenue. This was a slight decline year-over-year, reflecting headwinds in Canadian adult-use sales. Gross margins came in at roughly 32%, slightly below previous levels. The company continues to invest in high-growth segments like international medical cannabis and U.S. wellness products. Medical sales in Canada grew, while international exports showed modest gains. Despite these improvements, Canopy posted a large quarterly loss due to restructuring and overhead. Management has responded by cutting costs and repaying over $100 million in debt early. This will reduce annual interest expenses going forward. The goal is to improve cash flow and streamline operations ahead of a possible U.S. legalization breakthrough.

[Read More] Top U.S. Marijuana Stocks to Watch Now for a Potential Recovery

Village Farms International (VFF)

Village Farms began as a large-scale vegetable grower. However, it has since evolved into a leading low-cost cannabis producer. Its Canadian operations are managed under Pure Sunfarms, one of the country’s most profitable growers. In the U.S., the company sells hemp-derived wellness products through Balanced Health Botanicals. Although it does not operate dispensaries in the U.S., it has a strong online retail footprint. Village Farms also recently began expanding into Europe through the Netherlands. There, it is developing a commercial cannabis facility targeting the growing European market. With these multi-national efforts, the company is steadily growing its brand beyond Canada.

Latest Financials

Village Farms posted quarterly revenue of roughly $83 million, showing steady growth from prior quarters. On a full-year basis, sales totaled over $336 million. This represented solid double-digit growth year-over-year. The Canadian cannabis division led the way, with flower sales rising significantly. However, the company did record a write-down of about $10 million on older inventory. This impacted profitability, though it was a non-cash event. Adjusted EBITDA was positive, helped by cost efficiencies and scale. Village Farms also generated over $10 million in positive operating cash flow. Despite challenges, the company received a Nasdaq extension to comply with minimum bid requirements. It continues to pursue cost controls while scaling up internationally. With improving fundamentals and exposure to both the U.S. and European markets, Village Farms is emerging as a long-term contender.

Investing in Growth: Canada’s Cannabis Market Leaders

These three Canadian cannabis companies are well worth watching in April 2025. Each has unique strategies for breaking into the U.S. market despite ongoing federal restrictions. Tilray focuses on beverages and distribution. Canopy leverages strategic acquisitions. Village Farms prioritizes profitability and international growth. Their financials reflect early recovery signs, though risks remain. Investors should continue monitoring quarterly earnings, debt levels, and U.S. legalization news. As the industry stabilizes, these names could offer strong upside potential for patient, risk-aware investors.

The post April 2025’s Canadian Cannabis Stock Picks: Growth and Opportunity appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

When it comes to finding marijuana stocks to buy a happy medium or silver lining at this time is tough to do. Not becuase the low share prices from some of the top-performing companies dont look appetizing. It is more due to the consistent falls in the sector no real upward push. Even as the cannabis industry as a whole is thriving and showing great long-term success.

The public sector is not seeing anything transfer over that would show investors that they can have the confidence to trade. With Donald Trump in office, many investors and legal operators feel unsafe and even more uncertain about what will unfold. But some feel things have progressed too far for any type of halt in the legal cannabis market around the USA.

Trump has even gone on record to say he feels that states should have the right to vote and set up procedures for new markets. These people who are more on the glass half full about legal cannabis see the long game as the way to go. Right now it is still too volatile and people are still measuring all the possibilities and potential industry outcomes. It is always a good idea to learn more about what is going on in the sector so you can stay in the know about what could happen as a marijuana stock investor.

Marijuana Stocks To Know About 2025

1. Tilray Brands, Inc. (NASDAQ:TLRY)
2. Cronos Group Inc. (NASDAQ:CRON)
3. Aurora Cannabis Inc. (NASDAQ:ACB)

Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

In the most recent news, Tilray has come in as number 4 on the Brewers Association 2024 annual report. Specifically for the top 50 craft brewing companies in the USA. This marks a notable rise from its previous position at #5, reflecting the company’s continued growth and success in the craft brewing industry.

Cronos Group Inc.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

It has been some time since the company has a new company update. Back in March 2025, the company announced the appointment of Anna Shlimak as Chief Financial Officer. Ms. Shlimak has been an integral part of Cronos’ leadership team for the last seven years.

Words From The Company

“I am incredibly pleased Anna Shlimak is stepping into the Chief Financial Officer role,” said Mike Gorenstein, President and Chief Executive Officer, Cronos.”

[Read More] Top U.S. Marijuana Stocks to Watch Now for a Potential Recovery

Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

In recent news the company introduces the first inhalable resin cartridges. This product is for patients in the United Kingdom. These products are available to patients in Canada and Australia.

[Read More] 3 Marijuana Stocks To Buy Now And Sell When The Sectors Up

Words From The Managing Director Aurora UK and Ireland

“As a company dedicated to patient care and ensuring we regularly listen to patient feedback – we recognized a real need for a convenient, and discreet consumption option and are excited to introduce a new cannabis format at a promised level of quality,” said Trisha Cassidy.

The post 3 Canadian Marijuana Stocks That Could See Big Future Gains appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..